Treating Peptic Ulcers in Elderly Patients

Though Peptic Ulcer Disease (PUD) has been on the decline in the general population, older people especially over the age of 65 are prone to suffer from this painful condition. Peptic ulcers are painful sores that occur inside the lining of your esophagus, stomach, & in the upper portion of your small intestine. Peptic Ulcer Disease is effectively treated by proton- pump inhibitors, including Esomeprazole. Sold as Nexium, the generic version, Esomeprazole is bio- equivalent & much cheaper, which drastically brings down medical bills.

It’s been found that older people with serious health conditions such as cardiovascular disease, cerebral vascular disease, diabetes, chronic kidney disease, degenerative joint disease succumb more to PUD than younger people. This maybe because they use prescription & OTC drugs like aspirin, or non- steroidal anti-inflammatory drugs (NSAIDs) that put them at increased risk of upper gastrointestinal (GI) injury or painful peptic ulcers.

Helicobacter pylori (HP) bacterial infection is the primary cause of Helicobacter pylori (HP) infection in younger adults & children. But in recent years it has been found that idiopathic peptic ulcers, that is, ulcers not caused by Helicobacter pylori (HP) bacteria, NSAIDs or other identifiable causes, develop in geriatric patients.

Recent studies have shown that Esomeprazole is more effective in controlling Peptic Ulcer Disease in geriatric patients than a placebo or other Proton Pump Inhibitors (PPIs). If you need to be on Esomeprazole for an extended period of time, talk to your doctor about a calcium supplement.

Generic Esomeprazole not only enables geriatric patients to keep their PUD & GERD conditions under control, they can keep their healthcare costs under control too. Buying from www.internationaldrugmart.com is not only convenient for elderly patients & for those who’re unable to move around, on- going loyalty & benefit programs further drive down drug costs.

Share

No Comments »

No comments yet.

RSS feed for comments on this post. TrackBack URL

Leave a comment

You must be logged in to post a comment.